$0.39
(6.07%)
0.31%
Add to watchlist
Create an alert
Stocks and Shares ISASight Sciences, Inc. is an eyecare technology company. The Company is focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. The Company operates through two segments: Surgical Glaucoma and Dry Eye. The product portfolio for the Surgical Glaucoma segment features the OMNI Surgical System, which is an implant-free glaucoma surgery technology indicated to reduce intraocular pressure in adult patients with primary open-angle glaucoma, and the SION Surgical Instrument is a bladeless, a manually operated device used in ophthalmic surgical procedures to excise trabecular meshwork. The product portfolio for the Dry Eye segment consists of the TearCare System (TearCare) for ophthalmologists and optometrists. TearCare is used by adult patients with evaporative dry eye disease due to meibomian gland disease (MGD), enabling clearance of gland obstructions by physicians to address the cause of dry eye disease.
Company Information
About this company
Key people
Paul Badawi
President, Chief Executive Officer, Co-Founder, Director
David Badawi
Co-Founder, Chief Technology Officer, Director
Jim Rodberg
Chief Financial Officer, Principal Financial Officer and Principal Accounting Officer, Treasurer
Alison Bauerlein
Chief Operating Officer, Principal Operating Officer
Manohar Raheja
Executive Vice President - Research and Development
Brenton Taylor
Executive Vice President - Operations
Jeremy Bragg Hayden
Chief Legal Officer
Staffan Encrantz
Independent Chairman of the Board
Gerhard F. Burbach
Independent Director
Tamara R. Fountain
Independent Director
Catherine Mazzacco
Independent Director
Donald J. Zurbay
Independent Director
Click to see more
Key facts
- Shares in issue52.87m
- EPICSGHT
- ISINUS82657M1053
- LocationUnited States
- SectorHealthcare
- IndustryMedical Equipment & Supplies
- Market cap$337.32m
- Employees216
- ExchangeNASDAQ
- Index
- Website
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.